8h
GlobalData on MSNJ&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UCTremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...
The Key Advances in Gastroenterology & Hepatology collection offers a unique series of specially commissioned ‘Year in Review’ articles that highlight the key discoveries made each year.
The mechanisms involved in the formation of the premetastatic niche in hepatocellular carcinoma (HCC) are not completely elucidated. Here, the authors show that matrix stiffness in HCC induces ...
Are you struggling with debilitating anxiety because of chronic family and relationship stress, and perfectionism? Does the same scenario keep replaying in your life like a bad movie? You have ...
People start therapy with a desire for change. Something innate reminds them that they could live differently. That feeling is always there; now you are here and ready to listen. Our goal is to ...
SAN FRANCISCO — Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 weeks of Omvoh therapy maintained those results through ...
Built-in AI and smart recommendations do the heavy lifting for you. Seamlessly use Forms with your favorite apps to connect with audiences where they are. Easily share surveys to collaborate across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results